2024 Volume 31 Issue 12 Pages 245-249
The safety of perinatal spinal cord stimulation (SCS) has not yet been confirmed. We report the case of a patient who continued to use SCS during the perinatal period, despite inadequate recharging due to weight gain. Case: At the age of 25, the patient developed right brachial plexus neuropathy and was treated with steroid pulse therapy. At the age of 27, she was referred to our department due to persistent fatigue, edema, and pain in the affected limb. Repeated brachial plexus blocks provided temporary relief. At the age of 28, she began using SCS, with an implantable pulse generator (IPG) placed in the buttock. At the age of 36, she reported pregnancy and used SCS nightly. She became aware of poor recharging after 34 weeks of pregnancy, during which her weight increased by 13 kg from her prepregnancy weight. She delivered vaginally at 38 weeks and 3 days and was discharged without complications. After delivery, the patient lost weight, and her IPG charge improved.
